RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+7.28%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$622M
AUM Growth
+$622M
Cap. Flow
-$103M
Cap. Flow %
-16.52%
Top 10 Hldgs %
70.49%
Holding
49
New
24
Increased
5
Reduced
10
Closed
5

Top Buys

1
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$64.2M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$37.9M
3
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
$22.1M
4
TGTX icon
TG Therapeutics
TGTX
$22M
5
LRMR icon
Larimar Therapeutics
LRMR
$14.4M

Top Sells

1
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$158M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
$51M
3
DYAX
DYAX CORPORATION
DYAX
$22M
4
RPRX
Repros Therapeutics Inc.
RPRX
$21.1M
5
SGMO icon
Sangamo Therapeutics
SGMO
$16.9M

Sector Composition

1 Healthcare 67.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
OCRX
26
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.05M 0.24%
417,476
-73,221
-15% -$359K
ALIM
27
DELISTED
Alimera Sciences, Inc.
ALIM
$1.32M 0.16%
16,248
-28,196
-63% -$2.29M
CDXS icon
28
Codexis
CDXS
$218M
$1.18M 0.14%
+504,279
New +$1.18M
PTCT icon
29
PTC Therapeutics
PTCT
$4.41B
$1.14M 0.13%
+25,800
New +$1.14M
AGIO icon
30
Agios Pharmaceuticals
AGIO
$2.36B
$1.08M 0.13%
+17,600
New +$1.08M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$102B
$1.04M 0.12%
+9,300
New +$1.04M
MACK
32
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.02M 0.12%
+14,794
New +$1.02M
RGEN icon
33
Repligen
RGEN
$6.54B
$896K 0.11%
+45,000
New +$896K
REGN icon
34
Regeneron Pharmaceuticals
REGN
$59.8B
$883K 0.1%
+2,450
New +$883K
BIIB icon
35
Biogen
BIIB
$20.8B
$860K 0.1%
+2,600
New +$860K
AMGN icon
36
Amgen
AMGN
$153B
$829K 0.1%
+5,900
New +$829K
CELG
37
DELISTED
Celgene Corp
CELG
$825K 0.1%
+8,700
New +$825K
ALKS icon
38
Alkermes
ALKS
$4.95B
$823K 0.1%
+19,200
New +$823K
KERX
39
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$814K 0.1%
+59,200
New +$814K
KYTH
40
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$745K 0.09%
+22,750
New +$745K
ACAD icon
41
Acadia Pharmaceuticals
ACAD
$4.34B
$743K 0.09%
+30,000
New +$743K
PBYI icon
42
Puma Biotechnology
PBYI
$258M
$740K 0.09%
+3,100
New +$740K
LUMO
43
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$643K 0.08%
+3,333
New +$643K
ARWR icon
44
Arrowhead Research
ARWR
$3.84B
– –
-604,346
Closed -$8.65M
ATHE
45
Alterity Therapeutics
ATHE
$75.1M
– –
0
– –
EYPT icon
46
EyePoint Pharmaceuticals
EYPT
$827M
– –
-255,566
Closed -$11.1M
NBIX icon
47
Neurocrine Biosciences
NBIX
$13.5B
– –
-68,968
Closed -$1.02M
IMMU
48
DELISTED
Immunomedics Inc
IMMU
– –
-1,000,000
Closed -$3.65M
RPRX
49
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-1,219,381
Closed -$21.1M
1
2